Buckwheat trypsin inhibitor

Buckwheat trypsin inhibitor has been studied in 3 papers since 2017: none in people yet, 3 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jun 1, 2026: “Buckwheat Trypsin Inhibitor Prolongs the Healthy Lifespan by Activating Mitochondrial Protein Import Stress in Caenorhabditis elegans”.

Intervention

3 papers study it11 findingsUpdated

See all 3 papers on buckwheat trypsin inhibitor

At a glance

The findings reach worms or flies, none yet in people. 2 independent labs in 1 country.

None of its findings points the other way.

Worms or flies: a single group. Cells, mice and humans: nothing yet.
  • 2 independent labs in 1 country
  • Funders: National Institutes of Health and 3 more
  • Model organisms3

What did studies of buckwheat trypsin inhibitor find?

10

Studies of buckwheat trypsin inhibitor measured 10 outcomes, among them autophagy, Systemic metabolic reprogramming and ATP production.

Autophagy

upin worms2

2 studies
  1. Buckwheat trypsin inhibitor activates autophagy in worms (inhibited by chloroquine in a reversal test).

    Model organismsinhibited by chloroquine in a reversal testrecombinant

  2. Buckwheat trypsin inhibitor activates autophagy in AD worms treated with rBTI.

    Model organismsin AD worms treated with rBTI

More on Autophagy

Systemic metabolic reprogramming

upin worms1

1 study
  1. Buckwheat trypsin inhibitor induces systemic metabolic reprogramming in worms with rewiring of amino acid and lipid metabolism.

    Model organismswith rewiring of amino acid and lipid metabolismrecombinant

ATP production

upin worms1

1 study
  1. Buckwheat trypsin inhibitor increases ATP production in worms (dependent on K20 and K23 residues).

    Model organismsdependent on K20 and K23 residuesrecombinant

More on ATP production

daf-16

upin worms1

1 study
  1. Buckwheat trypsin inhibitor activates daf-16 in worms (measured by transcriptional activity of DAF-16).

    Model organismsmeasured by transcriptional activity of DAF-16recombinant

More on daf-16

Mitochondrial damage

downin worms1

1 study
  1. Buckwheat trypsin inhibitor decreases mitochondrial damage in worms (N2 aging model and AM140 age-related disease model).

    Model organismsN2 aging model and AM140 age-related disease modelrecombinant

More on Mitochondrial damage

Insoluble protein

downin worms1

1 study
  1. Buckwheat trypsin inhibitor decreases insoluble protein in worms (N2 aging model and AM140 age-related disease model).

    Model organismsN2 aging model and AM140 age-related disease modelrecombinant

More on Insoluble protein

Motor function

upin worms1

1 study
  1. Buckwheat trypsin inhibitor improves motor function in worms (N2 aging model and AM140 age-related disease model).

    Model organismsN2 aging model and AM140 age-related disease modelrecombinant

Amyloid-beta

downin worms1

1 study
  1. Buckwheat trypsin inhibitor decreases amyloid-beta in AD worms treated with rBTI.

    Model organismsin AD worms treated with rBTI

More on Amyloid-beta

Paralysis

downin worms1

1 study
  1. Buckwheat trypsin inhibitor decreases paralysis in AD model C. elegans (CL4176).

    Model organismsin AD model C. elegans (CL4176)

Lifespan

upin worms1

1 study
  1. Buckwheat trypsin inhibitor extends lifespan in AD model C. elegans (CL4176).

    Model organismsin AD model C. elegans (CL4176)

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months